For his doctorate at Tel Aviv University in the School of Molecular Cell Biology and Biotechnology, Dr. Feiner worked on incorporating electronics into engineering cardiac patches that could both monitor the electrical activity of the tissue and intervene in its functionality.
In the Molecular Pharmacology Program at Memorial Sloan-Kettering Cancer Center, he plans to work on integrating the sensors that the lab there has already developed with the microelectronic devices he created during his doctoral work in order to study tumor and organ development from within. The goal is to develop better tools that will help gather more information on the early stages of tumor development, with the hope that these will lead to better methods for early diagnosis and treatment.
Dr. Feiner is fascinated with biotechnology because it is where creativity takes the lead, meets basic science and enables researchers to be in the forefront of change. He wants to help advance the field of biomedicine for both basic research and clinical applications. In addition, he aims to lead a group of students that will cement Israel’s position in an exclusive club of countries that will help revolutionize the world of biomedical research and regenerative medicine.